FDA approves new treatment for refractory multiple myeloma.
U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with…
U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with…
The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial…
The U.S. Food and Drug Administration approved Victoza (liraglutide) injection for treatment of pediatric patients…
The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of…
On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax…
World Malaria Day25 April 2019 After more than a decade of steady advances in fighting…
The U.S. Food and Drug Administration granted accelerated approval to Balversa (erdafitinib), a treatment for…
April 9, 2019 The U.S. Food and Drug Administration approved Evenity (romosozumab-aqqg) to treat osteoporosis…
When we think of interactions between medications, it is mostly drug-drug interactions that we take…
The U.S. Food and Drug Administration approved Mavenclad (cladribine) tablets to treat relapsing forms of…